Lazard Asset Management LLC Mei Pharma, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.54 - $2.74 $10,177 - $51,643
-18,848 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$2.33 - $3.37 $43,915 - $63,517
18,848 New
18,848 $50,000
Q4 2020

Feb 11, 2021
SELL
$2.6 - $3.32 $73,541 - $93,906
-28,285 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$2.46 - $4.27 $69,581 - $120,776
28,285 New
28,285 $88,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $362M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email